In-depth review of Arcanum Pulse, a non-custodial crypto trading bot on Telegram for Bybit. Features risk mitigation & a success-based fee model.

The Russian billionaire who founded messaging app Telegram is fighting infertility, but he isn’t using his wallet — he is using his own sperm. Pavel Durov, 41, has offered to cover the full cost of in ...

With the latest update, Telegram users can now create a passkey to instantly log in to their accounts without needing an SMS code or password. Here’s how to activate it. Since Apple and Google ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. Updated November 25 with a new warning from America’s Cyber ...

The new Telegram update brings its own implementation of Apple’s Liquid Glass design, and it works even if you’re not running iOS 26. Over the weekend, Telegram rolled out an update on iOS that ...

The message from an anonymous stranger was how Ms. D, a woman in her 20s, learned her ex-boyfriend had leaked her private photos and intimate videos in a private chat on a Chinese language Telegram ...

Russian regulators have moved to restrict usage of the popular messaging apps WhatsApp and Telegram, the latest in a major step to push Russians onto a newly launched government-managed "super app." ...

Abdullah is a certified Google IT Support Professional. @SpamBot is an official Telegram bot that helps users verify if their accounts are restricted due to spamming and provides steps to appeal.

This volume-leading Telegram-based crypto trading bot brings speed, advanced tools and a user-first approach to the DeFi trading space. Drawn by the promise of transparency and individualized control, ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...